| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_119d03d40f99e0ca07888583f0f483c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baf849d216e689ecc40ccc931a7a7bc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10 |
| filingDate |
1999-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ae6024a6800c9a713f747f69258255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_858c82b7aded42a0b49ec1185299aa51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e0fdde95044f5a13fffc6483eac6c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eac0f50ef0bcd1e60208162b02dbe509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b1222b1a44ed8e8f3fad05b94475cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6724edb82504facf10607df9d9be69b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4a1ef24edb907a9c59ee9a86b63a37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67541ba3bb4a352e7439048afaa2f2e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8cdb74a9d167930b52d94fbef21f49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7169b07ff3d76f52e0193f4724da9eaf |
| publicationDate |
2008-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2353956-C |
| titleOfInvention |
Remedial agent for erectile dysfunction |
| abstract |
The present invention provides a remedial agent for erectile dysfunction which comprises a 3(2H)-pyridazinone derivative represented by the formula (I): (see formula I) wherein each symbol is the same as defined in the specifi-cation or a pharmaceutically acceptable salt thereof as an active ingredient. |
| priorityDate |
1998-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |